# Diffuse Lymphadenopathy

Assessment:
-- History: *** timing, night sweats, fevers, weight loss, immune status, travel, exposures, meds, h/o cancer, autoimmune dx, viral illnesses
-- Clinical/Exam: *** nodes (location, size, tenderness, mobility), hepatosplenomegaly
-- Data: *** see below for first and second pass
-- Etiology/DDx: *** Infectious (HIV, EBV, CMV, STI), Autoimmune (SLE, sarcoid), Malignancy (leukemia/lymphoma, metastases)

The patient's HPI is notable for ***. Exam showed ***. Labwork and data were notable for ***. Taken together, the patient's presentation is most concerning for ***, with a differential including ***.

Plan:
-- First pass - CBC, HIV, GC/Ch, RPR, ANA; CXR
-- Second pass - EBV, CMV, HSV, HepB, TB, endemic mycoses; CT C/A/P, node biopsy
‍